MARY LOGAN: Open Payments
NPI 1235576810 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,303 in 52 payments from 11 companies in 2025. Trend: 2023 $1,037 · 2024 $1,051 · 2025 $2,303
Food & beverage: $1,427Travel & lodging: $876
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 14 | $1,342 |
| SCPHARMACEUTICALS INC. | 9 | $304 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $172 |
| E.R. Squibb & Sons, L.L.C. | 3 | $163 |
| Merck Sharp & Dohme LLC | 6 | $100 |
| PFIZER INC. | 4 | $92 |
| BridgeBio Pharma, Inc. | 2 | $40 |
| Alnylam Pharmaceuticals Inc. | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: CARDIOMEMS, FUROSCIX, JARDIANCE, CAMZYOS, VYNDAQEL, VERQUVO, Attruby, CAPVAXIVE.
Industry payments across SC — which companies pay providers there.
